Despite the exceptional progress in breast cancer pathogenesis, prognosis, diagnosis, and
treatment strategies, it remains a prominent cause of female mortality worldwide …

Glioblastoma (GBM) is known to be the most common and lethal primary malignant brain
tumor. Therapies against this neoplasia have a high percentage of failure, associated with …

Background Neuroblastoma (NB) represents the most frequent and aggressive form of
extracranial solid tumor of infants. Nucleolin (NCL) is a protein overexpressed and partially …

Because of their excellent capacity to significantly improve the bioavailability and solubility
of chemotherapy drugs, block copolymer micelles are widely utilized for chemotherapy drug …

Gliomas are the most frequent and deadly form of human primary brain tumors. Among
them, the most common and aggressive type is the high-grade glioblastoma multiforme …

Gliomas are the most frequent and deadly form of human primary brain tumors. Among
them, the most common and aggressive type is the high-grade glioblastoma multiforme …

Background/Aim: Glioma is a deadly form of brain cancer. Doxorubicin is cytotoxic against
glioma cells. However, the blood-brain barrier (BBB) limits its ability to be delivered to the …

Gliomas are the most common primary malignant tumors of the central nervous system, and
their conventional treatment involves maximal safe surgical resection combined with …

Introduction RNA interference is a promising therapy in glioma treatment. However, the
application of RNA interference has been limited in glioma therapy by RNA instability and …

The benefits of treating several types of cancers using immunotherapy have recently been
established. The overexpression of nucleolin (NCL) in a number of types of cancer provides …